ORTHOPEDIATRICS CORP Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

ORTHOPEDIATRICS CORP reported Revenue From Contract With Customer Excluding Assessed Tax of $236.35 million for the year ending 2025.

  • ORTHOPEDIATRICS CORP showed an increase of +15.4% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from ORTHOPEDIATRICS CORP's annual report (Form 10-K), filed with the SEC on March 4, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), ORTHOPEDIATRICS CORP's Revenue From Contract With Customer Excluding Assessed Tax has grown by 533.7%.
  • Historical annual values: Fiscal year 2025: $236.35 million | Fiscal year 2024: $204.73 million | Fiscal year 2023: $148.73 million | Fiscal year 2022: $122.29 million | Fiscal year 2021: $98.05 million | Fiscal year 2020: $71.08 million | Fiscal year 2019: $72.55 million | Fiscal year 2018: $57.56 million | Fiscal year 2017: $45.62 million | Fiscal year 2016: $37.30 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: